Clinical Trial

Child and Adolescent Registry for Participants With Narcolepsy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2021-05-21; most recent amendment 2024-08-13.
Trial Details
NCT Number NCT04899947
Lead Sponsor Jazz Pharmaceuticals
Conditions Narcolepsy
Enrollment 500 participants
Start Date 2020-10-10
Primary Completion 2024-10-01 (estimated)
Study Completion 2024-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-15